Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study.
Shuell De SouzaJeffrey Kahol de JongYlenia PeroneShishir ShettyMaria QurashiMathew VithayathilTahir ShahPaul RossLaura TemperleyVincent S YipAbhirup BanerjeeDominic BettingerLukas SturmHelen L ReevesDaniel GehJames OrrBenjamin AllenRobert P JonesRohini SharmaPublished in: Cancers (2023)
Interruption of routine healthcare services because of the COVID-19 pandemic caused severe delays in HCC treatment. However, DTT did not translate to reduced survival. Longer follow is important given the delay in therapy in those receiving curative therapy.